Cencora, Inc. is a large healthcare services and pharmaceutical distribution company with multi‑billion dollar revenues and a conservative debt profile but operating with very thin net margins.
The company shows durable top‑line per‑share expansion, with a five‑year revenue‑per‑share CAGR of 11.09% and recent one‑year revenue‑per‑share growth around 9.9%. The most recent per‑share level was $1,645.41, underscoring steady volume and pricing progress (EPS Diluted & Revenue per Share, Revenue & Net Income).
Cash generation is a clear strength: trailing twelve‑month operating cash flow most recently was $3.48B, exceeding the TTM net income of $2.55B. Operating cash flow peaked at $3.91B in 2023, which supports operating liquidity and internal funding (Earnings Quality Analysis, Strategic Capital Allocation).
Leverage metrics are conservative on an ongoing basis, with interest coverage of 7.49x, debt‑to‑equity at 0.0025 and a net‑debt measure effectively at 0.00 relative to owner earnings.
Notable weaknesses include very low profitability: the most recent reported net profit margin was 0.5% (period ending 2025‑09‑30), and diluted EPS growth has lagged top‑line per‑share gains — one‑year diluted EPS growth was just 2.7% versus ~9.9% for revenue per share in the comparable period (Profit Margin Trends, Revenue & EPS Growth).
Liquidity at the working‑capital level is also a concern: the current ratio stands at 0.9467, below 1.0, signaling tighter short‑term coverage even as interest coverage remains comfortable.
Return on equity has been volatile, with the most recent quarterly ROE at 3.2% after prior extreme spikes, highlighting variability in capital returns (Return on Equity (ROE)).
The market multiple has also moved materially, with the trailing P/E at 24.1x after falling from the high‑30s in 2025 (Price-to-Earnings (PE) Ratio Trend).
Key fundamentals to monitor going forward are net profit margin (baseline 0.5%), the relationship of operating cash flow to net income (OCF $3.48B vs net income $2.55B), revenue‑per‑share growth (five‑year CAGR 11.09% and recent ~9.9%), diluted EPS progress (most recent EPS $13.05 and one‑year growth 2.7%), the current ratio (0.9467) and interest coverage (7.49x), and quarterly ROE (3.2%) and P/E dynamics (most recent 24.1x) as signals of margin recovery, liquidity improvement, and investor re‑rating.
The foundation of business quality and long-term value creation
Cencora, Inc.'s reported quarterly revenue has generally been in the $60–$82 billion range across recent quarters, with revenues of $68.41B (2024-03-31), $81.49B (2024-12-31), $80.66B (2025-06-30) and $78.36B (2026-03-31). The series also contains several notably larger single-quarter figures (e.g., $159.18B on 2025-09-30, $178.96B on 2022-09-30 and other $130–$180 billion observations), which stand out as inflection points relative to the more typical sub-$85B quarters.
Net income has shown greater quarter-to-quarter variability. After mid-range positive quarters through 2024 and early 2025 (frequent values between roughly $400M and $800M), net income swung to a loss of -$339.7M on 2025-09-30, recovered to $559.6M by 2025-12-31 and then increased to $1.64B in the most recent quarter. The most recent quarterly revenue was $78.36B. The most recent quarterly net income was $1.64B.
Why Growth Matters
Consistent revenue and earnings growth are the lifeblood of successful long-term investments. Companies that can grow their top line (revenue) and bottom line (net income) over many years demonstrate they have products or services customers value and are willing to pay for repeatedly.
Revenue Growth shows whether the company is expanding its market reach, gaining market share, or successfully launching new products.Net Income Growth demonstrates the company can convert that revenue into actual profits while managing costs effectively.
Look for steady, sustainable growth rather than erratic spikes. The best businesses compound earnings year after year, creating tremendous value for shareholders over time. Companies that can grow earnings faster than revenue are improving their profitability—a sign of operational excellence and competitive strength.
Year-over-year growth rates for revenue and earnings per share
Reading the Growth Rate Chart
This chart converts the absolute per-share figures into year-over-year percentage changes, making it easy to see whether growth is accelerating, decelerating, or reverting to trend — regardless of the company's absolute size.
Revenue per Share Growth (1-year, split-adjusted) measures how quickly the top line is expanding on a per-share basis. Sustained positive growth signals that the company continues to win customers and grow its addressable market.EPS Diluted Growth (1-year, split-adjusted) measures how quickly earnings are compounding for each shareholder. When EPS growth consistently outpaces revenue growth, operating leverage and margin expansion are at work.
Look for consistency, not just magnitude. A company that reliably grows EPS 10–15% per year is far more valuable than one that alternates between 50% spikes and deep contractions. Negative EPS growth during a period of positive revenue growth is a red flag — costs are rising faster than sales. Quarters where both lines converge near zero or go negative deserve close scrutiny.
How revenue converts to net income for the most recent annual period
Over the period Oct 2024 to Sep 2025, Cencora Inc generates $321.33B in revenue. After accounting for taxes and expenses, the company retains 0.5% as net profit margin, resulting in $1.55B in net earnings from $321.33B in revenue.
Period Information
Report Type: Annual (10-K)
Period: Oct 2024 to Sep 2025
Analyzing long-term margin stability and competitive positioning
Cencora, Inc.'s net profit margin has trended modestly lower in the most recent data points: after 0.7% in the 2022 and 2023 year-ends, the latest reported net profit margin declined to 0.5% for the period ending 2025-09-30. Earlier historical readings show variability at low single-digit levels (0.9% in 2011 and 0.5% in 2013), but the most recent quarter indicates a slight reduction versus the mid-decade readings.
Gross and operating margins are only reported through 2021 in this dataset. Gross margin rose to 3.2% as of 2021-09-30 from 2.6% in 2015, and operating margin increased to 1.1% in 2021 from 0.3% in 2015, indicating improvement over that multi-year span.
Understanding Profit Margins
Between Oct 2024 and Sep 2025, Cencora Inc converts every dollar of revenue through the following stages:
Sustainable competitive advantages reveal themselves through consistently superior profit margins over extended periods. Companies with durable economic moats maintain pricing power and operational efficiency that competitors struggle to match.
A sign of durable competitive advantage is earning sustained higher margins than competitors.Look for margins that remain stable or improve over time, especially during economic downturns. Declining margins may signal increasing competition, pricing pressure, or deteriorating business fundamentals.
Comparing reported earnings to actual cash generation
Cencora, Inc.'s trailing twelve‑month net income has moved higher in the most recent quarters, rising from $1.55B at the 2025-09-30 TTM to $1.63B at 2025-12-31 TTM and reaching $2.55B as of the 2026-03-31 TTM. This recent uptick in reported earnings represents the strongest net income level in the series of quarterly TTM snapshots provided here.
Operating cash flow (TTM) has been higher than net income across the most recent comparable periods shown: it rose from $2.70B at 2022-09-30 TTM to a peak of $3.91B at 2023-09-30 TTM, then declined to $3.48B at 2024-09-30 TTM. As of the latest available observations, the TTM operating cash flow of $3.48B exceeds the TTM net income of $2.55B.
The Earnings vs. Cash Flow Gap
Reported earnings (Net Income) doesn't always reflect actual cash generation. Companies use accrual accounting, which recognizes revenue when earned and expenses when incurred—not when cash actually changes hands. This creates timing differences and opportunities for accounting discretion that can mask underlying business health.
Net Income (the "earnings" number) can be influenced by non-cash items like depreciation, stock-based compensation, and changes in accounting estimates.Operating Cash Flow, however, shows the actual cash the business generates from its core operations—a harder number to manipulate.
Trailing Twelve Months
What to Look For
Key Insight: Companies with durable competitive advantages typically show operating cash flow that meets or exceeds net income over time, demonstrating they convert accounting profits into actual cash that can be returned to shareholders or reinvested in the business.
Measuring management's efficiency at generating profits from shareholder capital
Cencora, Inc.'s ROE shows large volatility over the sample. After mid-teens/low-twenties readings in 2011–2012 (24.6% and 24.0%), ROE was 3.0% at the quarter ending 2022-09-30 before spiking to very large values in 2023 (334.3% at 2023-09-30 and 257.4% at 2023-12-31) and again registering 103.1% at 2025-09-30. Those elevated readings were followed by a sharp decline to 2.2% at 2025-12-31 and a modest uptick to 3.2% at 2026-03-31.
The most recent data points therefore show ROE back in the low single digits after the earlier extreme peaks. The most recent quarterly ROE was 3.2% (period ending 2026-03-31).
The Gold Standard of Profitability
Return on Equity (ROE) is a powerful measure of how effectively a company's management is using the money shareholders have invested. Calculated by dividing Net Income by Shareholders' Equity, it reveals how much profit is generated for every dollar of equity capital.
A consistently high ROE (typically above 15-20%) is often the signature of a "quality" business with a durable competitive advantage. It indicates that the company can generate high returns on its own capital, which it can then reinvest at these high rates to compound value over time.
What to Look For:
How the company generates and deploys its cash
Cencora, Inc.'s trailing twelve-month operating cash flow rose from $2.70B at the 2022-09-30 TTM point to a peak of $3.91B at 2023-09-30, then moderated to $3.48B for the TTM ending 2024-09-30, indicating stronger operating cash generation in 2023 with a partial pullback in the most recent year.
Investing cash flow shows a large outflow spike earlier (notably -$6.14B at the 2021-09-30 TTM), but has since moved to a much smaller net outflow of -$618.1M for the TTM ending 2024-09-30, reflecting a substantial reduction in net investing cash outflows versus that prior peak.
Financing cash flow has been negative in the historical series provided, with the most recent reported TTM financing cash flow of -$926.0M at 2020-12-31; earlier periods also show sizable outflows and occasional inflows, but no later financing TTM values are provided.
The most recent Operating Cash Flow (TTM) was $3.48B, Investing Cash Flow (TTM) was -$618.1M, and Financing Cash Flow (TTM) was -$926.0M.
Understanding Company Strategy
Capital allocation refers to how management decides to spend and invest the company's cash. Analyzing the three primary categories of cash flow reveals a company's true operational strategy:
What to look for: Is the company bootstrapping (funding growth solely from operating cash)? Are they borrowing to fund aggressive expansion or dividends? Or are they capital raising by issuing new shares, potentially diluting your ownership? A healthy, mature company typically generates strong operating cash, moderately invests in growth, and returns the surplus to shareholders through financing activities.
Trailing Twelve Months
Net assets attributable to each share — the accounting floor of intrinsic value
Why Book Value per Share Matters
Book value per share is the net worth of the company — total assets minus total liabilities — divided by shares outstanding (split-adjusted). It represents the theoretical liquidation value per share if every asset were sold and every liability repaid at balance-sheet carrying values. It is the accounting foundation upon which much of equity valuation is built.
A steadily rising book value per share is one of the most reliable signals of compounding wealth creation. It means the company is retaining earnings and building net worth faster than it is returning capital or eroding it. Warren Buffett famously tracked Berkshire Hathaway's book value per share for decades as his primary measure of intrinsic value growth.
Context is essential. Asset-heavy businesses (banks, manufacturers, utilities) should be judged by book value more directly than asset-light businesses (software, consumer brands), where intangible assets like intellectual property and customer loyalty may far exceed their balance-sheet carrying values. A company trading at a large premium to book value is not necessarily overvalued — it may simply possess competitive advantages that accounting rules do not capture. Conversely, a declining book value per share — especially over multiple years — is a serious warning sign of capital destruction.
How much of the company is financed by debt versus shareholders' equity
Reading the Debt-to-Equity Ratio
The debt-to-equity (D/E) ratio compares total financial debt to shareholders' equity. A ratio of 1.0 means the company has borrowed one dollar for every dollar of equity; a ratio of 2.0 means it has borrowed twice as much as it owns. Financial leverage amplifies both returns and risk: in good times, debt turbocharges equity returns; in bad times, it accelerates losses and can threaten solvency.
Trends matter more than a single number. A rising D/E ratio can mean the company is taking on debt to fund growth — potentially value-creating if returns exceed the cost of capital. But it can also mean equity is being eroded through losses or that the business is borrowing simply to sustain operations. A falling D/E ratio generally reflects strengthening financial health: earnings are being retained, debt maturities are being paid down, or both.
Industry norms vary enormously. Capital-intensive sectors (utilities, real estate, financials) routinely carry high D/E ratios that would be alarming in, say, a technology company. Always compare against sector peers. As a rough rule of thumb, a D/E above 2× in a cyclical business warrants careful scrutiny of interest coverage and refinancing risk.
Short-term liquidity — can the company cover its near-term obligations?
Liquidity: Can the Business Pay Its Bills?
The current ratio is calculated as current assets divided by current liabilities. A ratio of 1.5 means the company has $1.50 of short-term assets — cash, receivables, inventory — for every $1.00 of obligations due within the next twelve months. It is the most direct measure of near-term financial resilience: can the business meet its obligations without needing to raise new capital or sell long-term assets at a discount?
A ratio above 1.0 is generally healthy, meaning current assets exceed current liabilities. A ratio consistently above 2.0 may indicate the company is holding excess cash or inventory that could be deployed more productively. A ratio below 1.0 is a warning sign — the company is relying on future cash generation or external financing to cover its near-term obligations, which is manageable in normal conditions but dangerous during a downturn.
Trends and context matter.A declining current ratio isn't always alarming — highly efficient businesses (e.g., large retailers with reliable daily cash flows) often run leaner balance sheets intentionally. Conversely, a rapidly rising current ratio can signal slowing sales causing inventory to build, or customers taking longer to pay. Always compare the trend against industry peers and cross-reference with the cash flow statement to assess whether the business is genuinely liquid or just holding non-cash current assets.
How much the market is paying for each dollar of company earnings
Cencora, Inc.'s trailing twelve-month P/E rose markedly from 15.6x on 2022-09-30 to the high‑30s in 2025, hitting 39.3x on 2025-09-30 and 40.6x on 2025-12-31. That multi-quarter expansion contrasts with earlier readings around 17.4x on 2023-12-31 and 20.0x on 2023-09-30, showing a clear upward move through 2024–2025 followed by a recent shift.
The most notable inflection is a sharp decline in the most recent quarter: the P/E fell from 40.6x at 2025-12-31 to 24.1x at 2026-03-31. Older historical points show variability (e.g., 27.5x at 2013-09-30 and ~10.3–10.8x in 2011–2012), but the immediate pattern is a rapid de-rating from late‑2025 into Q1 2026. The most recent P/E ratio was 24.1x.
What Is the PE Ratio?
The Price-to-Earnings (PE) ratio is one of the most widely used valuation metrics in investing. It divides the current stock price by the company's earnings per share (EPS), revealing how much investors are willing to pay for each dollar of earnings. A high PE can signal that the market expects strong future growth, while a low PE may suggest undervaluation—or reflect genuine concerns about the company's prospects.
Context matters:PE ratios vary significantly across industries. High-growth technology companies routinely trade at PE ratios above 30x or 40x, while mature, low-growth sectors like utilities or financials often trade closer to 10–15x. Always compare a company's PE to its own history and its industry peers, not just an absolute number.
What to Look For:
Key Insight:The PE ratio is a snapshot of market sentiment and expectations. Tracking it over time alongside earnings trends reveals whether the market's valuation has expanded or contracted—and whether that change is justified by fundamentals.